 Felix Poppelaars
Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Complement System Proteins | 13 | 2025 | 316 | 3.520 |
Why?
| | Complement Activation | 18 | 2025 | 411 | 2.380 |
Why?
| | Kidney Diseases | 7 | 2023 | 427 | 1.770 |
Why?
| | Peritoneal Dialysis | 3 | 2023 | 100 | 1.430 |
Why?
| | Renal Dialysis | 5 | 2019 | 462 | 1.310 |
Why?
| | Kidney Failure, Chronic | 7 | 2025 | 598 | 1.290 |
Why?
| | Interleukin-6 | 4 | 2022 | 780 | 1.270 |
Why?
| | Complement Factor H | 6 | 2026 | 80 | 1.160 |
Why?
| | Brain Death | 3 | 2019 | 60 | 1.150 |
Why?
| | Kidney Transplantation | 6 | 2025 | 704 | 1.090 |
Why?
| | Graft Rejection | 4 | 2026 | 540 | 0.930 |
Why?
| | Macular Degeneration | 3 | 2025 | 191 | 0.920 |
Why?
| | Inflammation | 3 | 2021 | 2880 | 0.770 |
Why?
| | Tissue Donors | 4 | 2025 | 424 | 0.740 |
Why?
| | Receptors, Interleukin-6 | 1 | 2021 | 47 | 0.680 |
Why?
| | Autoimmune Diseases | 1 | 2025 | 463 | 0.660 |
Why?
| | Interleukin-10 | 1 | 2022 | 310 | 0.650 |
Why?
| | Receptors, Complement | 1 | 2021 | 125 | 0.640 |
Why?
| | Biomedical Research | 1 | 2025 | 710 | 0.560 |
Why?
| | Complement C1 Inhibitor Protein | 1 | 2018 | 11 | 0.540 |
Why?
| | Mannose-Binding Lectin | 2 | 2016 | 20 | 0.520 |
Why?
| | Complement C3 | 1 | 2018 | 191 | 0.520 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4569 | 0.500 |
Why?
| | Dialysis Solutions | 3 | 2023 | 23 | 0.500 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2023 | 653 | 0.500 |
Why?
| | Receptor, Anaphylatoxin C5a | 1 | 2017 | 35 | 0.500 |
Why?
| | Kidney | 8 | 2023 | 1496 | 0.460 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 2171 | 0.440 |
Why?
| | Reperfusion Injury | 1 | 2017 | 300 | 0.410 |
Why?
| | Pandemics | 1 | 2022 | 1695 | 0.400 |
Why?
| | Kidney Glomerulus | 2 | 2025 | 128 | 0.370 |
Why?
| | Properdin | 3 | 2023 | 9 | 0.360 |
Why?
| | Glomerulonephritis | 2 | 2023 | 45 | 0.350 |
Why?
| | Complement Factor B | 2 | 2022 | 106 | 0.310 |
Why?
| | Research Personnel | 2 | 2022 | 186 | 0.310 |
Why?
| | Animals | 16 | 2025 | 38109 | 0.310 |
Why?
| | Humans | 31 | 2026 | 144957 | 0.290 |
Why?
| | Allografts | 2 | 2022 | 150 | 0.280 |
Why?
| | Complement C1q | 3 | 2023 | 33 | 0.270 |
Why?
| | Antibodies, Monoclonal | 3 | 2025 | 1524 | 0.250 |
Why?
| | Complement C3b Inactivator Proteins | 1 | 2026 | 9 | 0.250 |
Why?
| | Complement Factor D | 2 | 2023 | 28 | 0.240 |
Why?
| | Immunoglobulin M | 2 | 2025 | 284 | 0.230 |
Why?
| | Annexin A2 | 1 | 2025 | 13 | 0.230 |
Why?
| | Antibodies, Anticardiolipin | 1 | 2025 | 7 | 0.230 |
Why?
| | Choroid | 1 | 2025 | 80 | 0.220 |
Why?
| | Delayed Graft Function | 1 | 2025 | 46 | 0.220 |
Why?
| | Infliximab | 1 | 2025 | 108 | 0.220 |
Why?
| | Pancreatic Elastase | 1 | 2023 | 55 | 0.200 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2023 | 56 | 0.200 |
Why?
| | Complement C3d | 3 | 2023 | 67 | 0.200 |
Why?
| | Risk Factors | 4 | 2025 | 10792 | 0.200 |
Why?
| | Pemphigoid, Bullous | 1 | 2023 | 7 | 0.190 |
Why?
| | Complement C3b | 1 | 2023 | 30 | 0.190 |
Why?
| | Complement Membrane Attack Complex | 3 | 2019 | 38 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2025 | 851 | 0.190 |
Why?
| | Biopsy | 3 | 2021 | 1077 | 0.190 |
Why?
| | Maltose | 2 | 2019 | 8 | 0.180 |
Why?
| | Complement Inactivating Agents | 2 | 2020 | 74 | 0.180 |
Why?
| | Lectins | 2 | 2020 | 45 | 0.180 |
Why?
| | Ferric Compounds | 2 | 2019 | 55 | 0.180 |
Why?
| | CD59 Antigens | 1 | 2020 | 20 | 0.170 |
Why?
| | Rats, Inbred F344 | 2 | 2019 | 268 | 0.170 |
Why?
| | Peritoneum | 1 | 2020 | 45 | 0.160 |
Why?
| | Glomerular Filtration Rate | 2 | 2025 | 760 | 0.160 |
Why?
| | Atypical Hemolytic Uremic Syndrome | 1 | 2020 | 21 | 0.160 |
Why?
| | Antigen-Antibody Complex | 1 | 2020 | 72 | 0.160 |
Why?
| | Complement C4b | 1 | 2020 | 9 | 0.160 |
Why?
| | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2020 | 24 | 0.160 |
Why?
| | Glomerulonephritis, IGA | 1 | 2020 | 12 | 0.160 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2020 | 17 | 0.160 |
Why?
| | Oligosaccharides | 1 | 2020 | 60 | 0.150 |
Why?
| | Kaplan-Meier Estimate | 2 | 2026 | 966 | 0.150 |
Why?
| | Pneumothorax | 1 | 2019 | 51 | 0.150 |
Why?
| | Endometriosis | 1 | 2019 | 57 | 0.150 |
Why?
| | Delayed Diagnosis | 1 | 2019 | 95 | 0.150 |
Why?
| | Liver Transplantation | 1 | 2026 | 823 | 0.150 |
Why?
| | Male | 13 | 2026 | 72406 | 0.140 |
Why?
| | Heparin | 1 | 2020 | 244 | 0.140 |
Why?
| | Hemodiafiltration | 1 | 2018 | 7 | 0.140 |
Why?
| | von Willebrand Factor | 1 | 2018 | 85 | 0.140 |
Why?
| | Anemia | 1 | 2019 | 188 | 0.130 |
Why?
| | Prognosis | 3 | 2025 | 4293 | 0.130 |
Why?
| | Iron Compounds | 1 | 2016 | 7 | 0.130 |
Why?
| | Reproducibility of Results | 2 | 2025 | 3415 | 0.130 |
Why?
| | Hematinics | 1 | 2016 | 22 | 0.120 |
Why?
| | Morbidity | 1 | 2018 | 323 | 0.120 |
Why?
| | Neutrophil Activation | 1 | 2017 | 85 | 0.120 |
Why?
| | Female | 13 | 2026 | 78376 | 0.120 |
Why?
| | Mice | 7 | 2025 | 18365 | 0.120 |
Why?
| | Follow-Up Studies | 3 | 2025 | 5417 | 0.120 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 62 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 475 | 0.120 |
Why?
| | Risk | 1 | 2018 | 911 | 0.120 |
Why?
| | Biomarkers | 3 | 2025 | 4275 | 0.120 |
Why?
| | Leukocytes | 1 | 2017 | 295 | 0.110 |
Why?
| | Mortality | 1 | 2018 | 376 | 0.110 |
Why?
| | Mice, Knockout | 2 | 2025 | 3125 | 0.110 |
Why?
| | Thrombosis | 1 | 2018 | 393 | 0.110 |
Why?
| | Cause of Death | 1 | 2016 | 472 | 0.100 |
Why?
| | Toll-Like Receptor 2 | 1 | 2014 | 126 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2147 | 0.100 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 1217 | 0.100 |
Why?
| | Aged, 80 and over | 3 | 2025 | 8279 | 0.100 |
Why?
| | Sex Characteristics | 1 | 2018 | 791 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2014 | 276 | 0.090 |
Why?
| | Cell Movement | 1 | 2017 | 965 | 0.090 |
Why?
| | Middle Aged | 6 | 2025 | 35928 | 0.090 |
Why?
| | Rats | 2 | 2018 | 5614 | 0.090 |
Why?
| | Neutrophils | 1 | 2017 | 1134 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 2118 | 0.080 |
Why?
| | Antibody Specificity | 2 | 2025 | 181 | 0.080 |
Why?
| | Prospective Studies | 1 | 2022 | 7997 | 0.080 |
Why?
| | Immunoglobulin G | 2 | 2025 | 893 | 0.080 |
Why?
| | Graft Survival | 2 | 2025 | 526 | 0.070 |
Why?
| | Adult | 6 | 2025 | 40506 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2017 | 2832 | 0.070 |
Why?
| | Cohort Studies | 1 | 2018 | 5965 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2609 | 0.070 |
Why?
| | Aging | 1 | 2018 | 1966 | 0.070 |
Why?
| | Aged | 4 | 2025 | 25947 | 0.070 |
Why?
| | Administration, Intravenous | 2 | 2019 | 170 | 0.070 |
Why?
| | Kidney Function Tests | 1 | 2025 | 157 | 0.050 |
Why?
| | Podocytes | 1 | 2025 | 80 | 0.050 |
Why?
| | Haplotypes | 1 | 2026 | 490 | 0.050 |
Why?
| | Blood Proteins | 1 | 2026 | 249 | 0.050 |
Why?
| | Tomography, Optical Coherence | 1 | 2025 | 271 | 0.050 |
Why?
| | Disease Progression | 2 | 2022 | 2852 | 0.050 |
Why?
| | Transplant Recipients | 1 | 2025 | 180 | 0.050 |
Why?
| | Complement Factor I | 1 | 2022 | 12 | 0.050 |
Why?
| | Epitopes | 1 | 2023 | 485 | 0.040 |
Why?
| | Doxorubicin | 1 | 2023 | 397 | 0.040 |
Why?
| | Fibrinogen | 1 | 2022 | 177 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2023 | 1253 | 0.040 |
Why?
| | Antibodies | 1 | 2023 | 403 | 0.040 |
Why?
| | Dexamethasone | 1 | 2023 | 372 | 0.040 |
Why?
| | Pleurodesis | 1 | 2019 | 3 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 255 | 0.040 |
Why?
| | Thoracoscopy | 1 | 2019 | 62 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2025 | 870 | 0.040 |
Why?
| | Peroxidase | 1 | 2019 | 168 | 0.040 |
Why?
| | Cattle | 1 | 2020 | 1000 | 0.030 |
Why?
| | Swine | 1 | 2020 | 833 | 0.030 |
Why?
| | Sheep | 1 | 2020 | 880 | 0.030 |
Why?
| | Glucaric Acid | 1 | 2016 | 4 | 0.030 |
Why?
| | Iron-Dextran Complex | 1 | 2016 | 7 | 0.030 |
Why?
| | Disaccharides | 1 | 2016 | 21 | 0.030 |
Why?
| | Ferrosoferric Oxide | 1 | 2016 | 25 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1135 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1048 | 0.030 |
Why?
| | Frozen Sections | 1 | 2014 | 24 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5997 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2020 | 676 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5872 | 0.030 |
Why?
| | Demography | 1 | 2014 | 288 | 0.030 |
Why?
| | Protein Binding | 1 | 2020 | 2276 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 3164 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 17101 | 0.020 |
Why?
| | Living Donors | 1 | 2014 | 280 | 0.020 |
Why?
| | Cytokines | 1 | 2019 | 2065 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2017 | 988 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1718 | 0.020 |
Why?
| | Lung | 1 | 2020 | 4109 | 0.020 |
Why?
| | Signal Transduction | 1 | 2018 | 5233 | 0.010 |
Why?
|
|
Poppelaars's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|